Natalizumab for relapsing multiple sclerosis [1] (multiple letters)

New England Journal of Medicine

Volumn 348, Issue 16, 2003, Pages 1598-1599

  Chaudhuri, Abhijit ^a   Behan, Peter O ^a   Miller, David H ^b   O'Connor, Paul W ^c  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NATALIZUMAB;

BLOOD BRAIN BARRIER; DISABILITY; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; DRUG INFUSION; FOLLOW UP; HUMAN; IMMUNOTHERAPY; LETTER; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREGNANCY; PRIORITY JOURNAL; RECURRENT DISEASE; SCORING SYSTEM;

EID: 0037451919     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200304173481614     Document Type: Letter

References (0)